ECSP067104A - USE OF RECEIVING LINGERS IN THERAPY - Google Patents

USE OF RECEIVING LINGERS IN THERAPY

Info

Publication number
ECSP067104A
ECSP067104A ECSP067104A ECSP067104A EC SP067104 A ECSP067104 A EC SP067104A EC SP067104 A ECSP067104 A EC SP067104A EC SP067104 A ECSP067104 A EC SP067104A
Authority
EC
Ecuador
Prior art keywords
lingers
therapy
receiving
allergic
ridobronchitis
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Trond Ulven
Thomas Frimurer
Oystein Rist
Evi Kostenis
Thomas Hoegberg
Jean Marie Receveur
Marie Grimstrup
Original Assignee
7Tm Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0412198A external-priority patent/GB0412198D0/en
Application filed by 7Tm Pharma As filed Critical 7Tm Pharma As
Publication of ECSP067104A publication Critical patent/ECSP067104A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Los compuestos de la fórmula (I) el tratamiento de una enfermedad que responde a la modulación de la actividad del receptor CRTH2, como es asma, rinitis, síndrome alérgico de vías aéreas y ridobronquitis alérgica.The compounds of the formula (I) the treatment of a disease that responds to the modulation of the activity of the CRTH2 receptor, such as asthma, rhinitis, allergic airway syndrome and allergic ridobronchitis.

ECSP067104 2004-05-29 2006-12-20 USE OF RECEIVING LINGERS IN THERAPY ECSP067104A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0412198A GB0412198D0 (en) 2004-05-29 2004-05-29 Medicinal use of receptor ligands

Publications (1)

Publication Number Publication Date
ECSP067104A true ECSP067104A (en) 2007-04-26

Family

ID=38131507

Family Applications (2)

Application Number Title Priority Date Filing Date
ECSP067104 ECSP067104A (en) 2004-05-29 2006-12-20 USE OF RECEIVING LINGERS IN THERAPY
ECSP067115 ECSP067115A (en) 2004-05-29 2006-12-26 MEDICAL USE OF RECEIVING LINGADOS

Family Applications After (1)

Application Number Title Priority Date Filing Date
ECSP067115 ECSP067115A (en) 2004-05-29 2006-12-26 MEDICAL USE OF RECEIVING LINGADOS

Country Status (4)

Country Link
CN (2) CN1980908A (en)
EC (2) ECSP067104A (en)
UA (1) UA85512C2 (en)
ZA (2) ZA200610597B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8674115B2 (en) 2009-12-23 2014-03-18 Ironwood Pharmaceuticals, Inc. CRTH2 modulators

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102016577B (en) * 2008-05-09 2015-06-17 希森美康株式会社 Blood analysis device, blood analysis method and hemolyzing agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8674115B2 (en) 2009-12-23 2014-03-18 Ironwood Pharmaceuticals, Inc. CRTH2 modulators

Also Published As

Publication number Publication date
ECSP067115A (en) 2007-03-29
ZA200610597B (en) 2008-01-30
CN1980664A (en) 2007-06-13
CN1980908A (en) 2007-06-13
UA85512C2 (en) 2009-01-26
ZA200610598B (en) 2008-01-30
CN1980664B (en) 2011-02-23

Similar Documents

Publication Publication Date Title
CL2016002589A1 (en) Use of compound genz-112638 (eliglustat), glucosylceramide synthase inhibitor, in the treatment of gaucher disease and fabry disease (divisional application 201201348).
ECSP045474A (en) 1- (AMINOALQUIL) -3-SULPHONYLAZAINDOLS AS 5-HYDROXYTHYRIPTAMINE-6 LIGANDS
CL2011000301A1 (en) Compounds derived from purine with immunomodulatory activity; pharmaceutical composition comprising them; and use of them in the treatment of allergic diseases, allergic rhinitis, asthma, infectious diseases and cancer.
ECSP077296A (en) SUBSTITUTED PHENYLAMINOTIAZOLS AND ITS USE
ECSP077340A (en) NEW DERIVATIVES OF PYRIMIDINE AND ITS USE AS MODULATORS OF PPAR-ALFA
CR9078A (en) DERIVED FROM BENCIMIDAZOL ARILOXI-SUBSTITUTES
ECSP10010310A (en) NEW COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
CR11478A (en) TOWEL TO CARRY
EA201100335A1 (en) PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-ASSOCIATED DISEASES
ECSP088866A (en) USE OF DPP IV INHIBITORS
UY31305A1 (en) DERIVATIVES OF 1,2,4,5-TETRAHIDRO-3H-BENZAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BRPI0511396A (en) Retinal Derivatives and Methods for Use in the Treatment of Visual Disorders
CU20100111A7 (en) 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE FOR THE TREATMENT AND PREVENTION OF PULMONARY AND CARDIOVASCULAR DISEASES
AR047928A1 (en) TETRAHYDROPIRIDOINDOL DERIVATIVES
UY28876A1 (en) SUBSTITUTED MORPHOLINE COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
CO6410278A2 (en) PEDIATRIC DISSOLUTIONS CONTAINING A BETA-BLOCKING
ECSP055964A (en) HETEROCICLIL-3-SULPHONYLINDAZOLS AS LIGANDS OF 5-HYDROXYTHYRIPTAMINE-6
UY28923A1 (en) THERAPEUTIC COMPOUNDS: PYRIDINE AS A BASE STRUCTURE
CR8837A (en) USE OF RECEIVER LIGANDS IN THERAPY
AR079945A1 (en) PIRAZINE DERIVATIVES AS INHIBITORS OF GLUCOGENO SINTASA QUINASA 3 (GSK3)
ECSP077277A (en) ARILSULPHONYLESTILBEN DERIVATIVES FOR INSOMNIA TREATMENT AND RELATED AFFECTIONS
CR9722A (en) DERIVATIVES OF BENZILPIPERAZINA AND ITS MEDICAL USE
CL2008001820A1 (en) Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.
ES2570332T3 (en) The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
ECSP10010464A (en) USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES